Hitting the nail on the head: overcoming therapeutic resistance in lung cancer

An interdisciplinary team at the Medical University of South Carolina has shown that Neuropilin 2, a protein highly expressed in lung cancer cells, is a critical player in conferring resistance to targeted therapy in lung cancer. Their findings are reported in an article published in The Journal of Thoracic and Cardiovascular Surgery.